The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Butylscopolamine Bromide Market Research Report 2024
Synopsis
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
The global Butylscopolamine Bromide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Butylscopolamine Bromide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Butylscopolamine Bromide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Butylscopolamine Bromide in Stomach is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Butylscopolamine Bromide include Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical and Jiangsu Ange Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Butylscopolamine Bromide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Butylscopolamine Bromide.
Report Scope
The Butylscopolamine Bromide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Butylscopolamine Bromide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Butylscopolamine Bromide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Boehringer Ingelheim
Sandoz (Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan Pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Wanbangde Pharmaceutical Group
Shandong Yijian Pharmaceutical
Segment by Type
Tablets
Capsule
Intramuscular Injection
Intravenous Or Drip
Suppositories
Other
Segment by Application
Stomach
Gas Barium Hypography
Abdominal CT Scan
Gastrointestinal Spasm
Biliary Colic
Renal Colic
Gastrointestinal Hypermotility
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Butylscopolamine Bromide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
The global Butylscopolamine Bromide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Butylscopolamine Bromide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Butylscopolamine Bromide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Butylscopolamine Bromide in Stomach is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Butylscopolamine Bromide include Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical and Jiangsu Ange Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Butylscopolamine Bromide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Butylscopolamine Bromide.
Report Scope
The Butylscopolamine Bromide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Butylscopolamine Bromide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Butylscopolamine Bromide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Boehringer Ingelheim
Sandoz (Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan Pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Wanbangde Pharmaceutical Group
Shandong Yijian Pharmaceutical
Segment by Type
Tablets
Capsule
Intramuscular Injection
Intravenous Or Drip
Suppositories
Other
Segment by Application
Stomach
Gas Barium Hypography
Abdominal CT Scan
Gastrointestinal Spasm
Biliary Colic
Renal Colic
Gastrointestinal Hypermotility
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Butylscopolamine Bromide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Butylscopolamine Bromide Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Intramuscular Injection
1.2.5 Intravenous Or Drip
1.2.6 Suppositories
1.2.7 Other
1.3 Market by Application
1.3.1 Global Butylscopolamine Bromide Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Stomach
1.3.3 Gas Barium Hypography
1.3.4 Abdominal CT Scan
1.3.5 Gastrointestinal Spasm
1.3.6 Biliary Colic
1.3.7 Renal Colic
1.3.8 Gastrointestinal Hypermotility
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Butylscopolamine Bromide Market Perspective (2019-2030)
2.2 Butylscopolamine Bromide Growth Trends by Region
2.2.1 Global Butylscopolamine Bromide Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Butylscopolamine Bromide Historic Market Size by Region (2019-2024)
2.2.3 Butylscopolamine Bromide Forecasted Market Size by Region (2025-2030)
2.3 Butylscopolamine Bromide Market Dynamics
2.3.1 Butylscopolamine Bromide Industry Trends
2.3.2 Butylscopolamine Bromide Market Drivers
2.3.3 Butylscopolamine Bromide Market Challenges
2.3.4 Butylscopolamine Bromide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Butylscopolamine Bromide Players by Revenue
3.1.1 Global Top Butylscopolamine Bromide Players by Revenue (2019-2024)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Players (2019-2024)
3.2 Global Butylscopolamine Bromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Butylscopolamine Bromide Revenue
3.4 Global Butylscopolamine Bromide Market Concentration Ratio
3.4.1 Global Butylscopolamine Bromide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Butylscopolamine Bromide Revenue in 2023
3.5 Butylscopolamine Bromide Key Players Head office and Area Served
3.6 Key Players Butylscopolamine Bromide Product Solution and Service
3.7 Date of Enter into Butylscopolamine Bromide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Butylscopolamine Bromide Breakdown Data by Type
4.1 Global Butylscopolamine Bromide Historic Market Size by Type (2019-2024)
4.2 Global Butylscopolamine Bromide Forecasted Market Size by Type (2025-2030)
5 Butylscopolamine Bromide Breakdown Data by Application
5.1 Global Butylscopolamine Bromide Historic Market Size by Application (2019-2024)
5.2 Global Butylscopolamine Bromide Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Butylscopolamine Bromide Market Size (2019-2030)
6.2 North America Butylscopolamine Bromide Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Butylscopolamine Bromide Market Size by Country (2019-2024)
6.4 North America Butylscopolamine Bromide Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Butylscopolamine Bromide Market Size (2019-2030)
7.2 Europe Butylscopolamine Bromide Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Butylscopolamine Bromide Market Size by Country (2019-2024)
7.4 Europe Butylscopolamine Bromide Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Butylscopolamine Bromide Market Size (2019-2030)
8.2 Asia-Pacific Butylscopolamine Bromide Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2019-2024)
8.4 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Butylscopolamine Bromide Market Size (2019-2030)
9.2 Latin America Butylscopolamine Bromide Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Butylscopolamine Bromide Market Size by Country (2019-2024)
9.4 Latin America Butylscopolamine Bromide Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Butylscopolamine Bromide Market Size (2019-2030)
10.2 Middle East & Africa Butylscopolamine Bromide Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2019-2024)
10.4 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Butylscopolamine Bromide Introduction
11.1.4 Sanofi Revenue in Butylscopolamine Bromide Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Introduction
11.2.4 Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Detail
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Introduction
11.3.4 Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2019-2024)
11.3.5 Sandoz (Novartis) Recent Development
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Detail
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Introduction
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2019-2024)
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Detail
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Business Overview
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Introduction
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2019-2024)
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Recent Development
11.6 Linnea
11.6.1 Linnea Company Detail
11.6.2 Linnea Business Overview
11.6.3 Linnea Butylscopolamine Bromide Introduction
11.6.4 Linnea Revenue in Butylscopolamine Bromide Business (2019-2024)
11.6.5 Linnea Recent Development
11.7 Alkaloida
11.7.1 Alkaloida Company Detail
11.7.2 Alkaloida Business Overview
11.7.3 Alkaloida Butylscopolamine Bromide Introduction
11.7.4 Alkaloida Revenue in Butylscopolamine Bromide Business (2019-2024)
11.7.5 Alkaloida Recent Development
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Detail
11.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Introduction
11.8.4 Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.8.5 Chengdu Tiantaishan Pharmaceutical Recent Development
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Detail
11.9.2 Jiangsu Ange Pharmaceutical Business Overview
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Introduction
11.9.4 Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.9.5 Jiangsu Ange Pharmaceutical Recent Development
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Detail
11.10.2 Chengdu First Pharmaceutical Business Overview
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Introduction
11.10.4 Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.10.5 Chengdu First Pharmaceutical Recent Development
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Detail
11.11.2 Beijing Zizhu Pharmaceutical Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Introduction
11.11.4 Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.11.5 Beijing Zizhu Pharmaceutical Recent Development
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Detail
11.12.2 Guangdong Zhongsheng Pharmaceutical Business Overview
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Introduction
11.12.4 Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.12.5 Guangdong Zhongsheng Pharmaceutical Recent Development
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Detail
11.13.2 Wanbangde Pharmaceutical Group Business Overview
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Introduction
11.13.4 Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2019-2024)
11.13.5 Wanbangde Pharmaceutical Group Recent Development
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Detail
11.14.2 Shandong Yijian Pharmaceutical Business Overview
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Introduction
11.14.4 Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024)
11.14.5 Shandong Yijian Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Butylscopolamine Bromide Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Intramuscular Injection
Table 5. Key Players of Intravenous Or Drip
Table 6. Key Players of Suppositories
Table 7. Key Players of Other
Table 8. Global Butylscopolamine Bromide Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Butylscopolamine Bromide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Butylscopolamine Bromide Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Butylscopolamine Bromide Market Share by Region (2019-2024)
Table 12. Global Butylscopolamine Bromide Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Butylscopolamine Bromide Market Share by Region (2025-2030)
Table 14. Butylscopolamine Bromide Market Trends
Table 15. Butylscopolamine Bromide Market Drivers
Table 16. Butylscopolamine Bromide Market Challenges
Table 17. Butylscopolamine Bromide Market Restraints
Table 18. Global Butylscopolamine Bromide Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Butylscopolamine Bromide Market Share by Players (2019-2024)
Table 20. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2023)
Table 21. Ranking of Global Top Butylscopolamine Bromide Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Butylscopolamine Bromide Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Butylscopolamine Bromide Product Solution and Service
Table 25. Date of Enter into Butylscopolamine Bromide Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Butylscopolamine Bromide Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Butylscopolamine Bromide Revenue Market Share by Type (2019-2024)
Table 29. Global Butylscopolamine Bromide Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Butylscopolamine Bromide Revenue Market Share by Type (2025-2030)
Table 31. Global Butylscopolamine Bromide Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Butylscopolamine Bromide Revenue Market Share by Application (2019-2024)
Table 33. Global Butylscopolamine Bromide Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Butylscopolamine Bromide Revenue Market Share by Application (2025-2030)
Table 35. North America Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Butylscopolamine Bromide Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Butylscopolamine Bromide Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Butylscopolamine Bromide Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Butylscopolamine Bromide Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Butylscopolamine Bromide Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Butylscopolamine Bromide Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Butylscopolamine Bromide Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2025-2030) & (US$ Million)
Table 50. Sanofi Company Detail
Table 51. Sanofi Business Overview
Table 52. Sanofi Butylscopolamine Bromide Product
Table 53. Sanofi Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 54. Sanofi Recent Development
Table 55. Boehringer Ingelheim Company Detail
Table 56. Boehringer Ingelheim Business Overview
Table 57. Boehringer Ingelheim Butylscopolamine Bromide Product
Table 58. Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 59. Boehringer Ingelheim Recent Development
Table 60. Sandoz (Novartis) Company Detail
Table 61. Sandoz (Novartis) Business Overview
Table 62. Sandoz (Novartis) Butylscopolamine Bromide Product
Table 63. Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 64. Sandoz (Novartis) Recent Development
Table 65. Boehringer Ingelheim Pharma GmbH & Co. KG Company Detail
Table 66. Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
Table 67. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product
Table 68. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 69. Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
Table 70. XI AN TIANXINGJIAN PHARMCHEM Company Detail
Table 71. XI AN TIANXINGJIAN PHARMCHEM Business Overview
Table 72. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product
Table 73. XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 74. XI AN TIANXINGJIAN PHARMCHEM Recent Development
Table 75. Linnea Company Detail
Table 76. Linnea Business Overview
Table 77. Linnea Butylscopolamine Bromide Product
Table 78. Linnea Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 79. Linnea Recent Development
Table 80. Alkaloida Company Detail
Table 81. Alkaloida Business Overview
Table 82. Alkaloida Butylscopolamine Bromide Product
Table 83. Alkaloida Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 84. Alkaloida Recent Development
Table 85. Chengdu Tiantaishan Pharmaceutical Company Detail
Table 86. Chengdu Tiantaishan Pharmaceutical Business Overview
Table 87. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product
Table 88. Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 89. Chengdu Tiantaishan Pharmaceutical Recent Development
Table 90. Jiangsu Ange Pharmaceutical Company Detail
Table 91. Jiangsu Ange Pharmaceutical Business Overview
Table 92. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product
Table 93. Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 94. Jiangsu Ange Pharmaceutical Recent Development
Table 95. Chengdu First Pharmaceutical Company Detail
Table 96. Chengdu First Pharmaceutical Business Overview
Table 97. Chengdu First Pharmaceutical Butylscopolamine Bromide Product
Table 98. Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 99. Chengdu First Pharmaceutical Recent Development
Table 100. Beijing Zizhu Pharmaceutical Company Detail
Table 101. Beijing Zizhu Pharmaceutical Business Overview
Table 102. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product
Table 103. Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 104. Beijing Zizhu Pharmaceutical Recent Development
Table 105. Guangdong Zhongsheng Pharmaceutical Company Detail
Table 106. Guangdong Zhongsheng Pharmaceutical Business Overview
Table 107. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product
Table 108. Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 109. Guangdong Zhongsheng Pharmaceutical Recent Development
Table 110. Wanbangde Pharmaceutical Group Company Detail
Table 111. Wanbangde Pharmaceutical Group Business Overview
Table 112. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product
Table 113. Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 114. Wanbangde Pharmaceutical Group Recent Development
Table 115. Shandong Yijian Pharmaceutical Company Detail
Table 116. Shandong Yijian Pharmaceutical Business Overview
Table 117. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product
Table 118. Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2019-2024) & (US$ Million)
Table 119. Shandong Yijian Pharmaceutical Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Butylscopolamine Bromide Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Butylscopolamine Bromide Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Intramuscular Injection Features
Figure 6. Intravenous Or Drip Features
Figure 7. Suppositories Features
Figure 8. Other Features
Figure 9. Global Butylscopolamine Bromide Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Butylscopolamine Bromide Market Share by Application: 2023 VS 2030
Figure 11. Stomach Case Studies
Figure 12. Gas Barium Hypography Case Studies
Figure 13. Abdominal CT Scan Case Studies
Figure 14. Gastrointestinal Spasm Case Studies
Figure 15. Biliary Colic Case Studies
Figure 16. Renal Colic Case Studies
Figure 17. Gastrointestinal Hypermotility Case Studies
Figure 18. Other Case Studies
Figure 19. Butylscopolamine Bromide Report Years Considered
Figure 20. Global Butylscopolamine Bromide Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 21. Global Butylscopolamine Bromide Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 22. Global Butylscopolamine Bromide Market Share by Region: 2023 VS 2030
Figure 23. Global Butylscopolamine Bromide Market Share by Players in 2023
Figure 24. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2023)
Figure 25. The Top 10 and 5 Players Market Share by Butylscopolamine Bromide Revenue in 2023
Figure 26. North America Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. North America Butylscopolamine Bromide Market Share by Country (2019-2030)
Figure 28. United States Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Canada Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Butylscopolamine Bromide Market Share by Country (2019-2030)
Figure 32. Germany Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Butylscopolamine Bromide Market Share by Region (2019-2030)
Figure 40. China Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Japan Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Butylscopolamine Bromide Market Share by Country (2019-2030)
Figure 48. Mexico Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Brazil Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Butylscopolamine Bromide Market Share by Country (2019-2030)
Figure 52. Turkey Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Butylscopolamine Bromide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Sanofi Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 56. Sandoz (Novartis) Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 57. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 58. XI AN TIANXINGJIAN PHARMCHEM Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 59. Linnea Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 60. Alkaloida Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 61. Chengdu Tiantaishan Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 62. Jiangsu Ange Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 63. Chengdu First Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 64. Beijing Zizhu Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 65. Guangdong Zhongsheng Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 66. Wanbangde Pharmaceutical Group Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 67. Shandong Yijian Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
